These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25716285)

  • 1. The unintended effects of the Medicare Part D low income subsidy.
    Decarolis F
    Health Policy; 2015 May; 119(5):597-603. PubMed ID: 25716285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare Part D: Are Insurers Gaming the Low Income Subsidy Design?
    Decarolis F
    Am Econ Rev; 2015 Apr; 105(4):1547-80. PubMed ID: 29542882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Medicare drug benefit: update on the low-income subsidy.
    Stahlman ME
    Issue Brief George Wash Univ Natl Health Policy Forum; 2009 Jul; (833):1-22. PubMed ID: 19685590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the prescription drug plans delivering the Medicare Part D prescription drug benefit.
    Brill JV
    Am J Health Syst Pharm; 2007 Aug; 64(15 Suppl 10):S3-6; quiz S21-S23. PubMed ID: 17646551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affordability and adherence gains for Medicare Part D low-income subsidy recipients when low-income subsidy benefits expanded in 2024.
    Stuart BC; Loh FE; Dougherty JS
    J Manag Care Spec Pharm; 2024 Jul; 30(7):728-735. PubMed ID: 38950158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amendments to regulations regarding eligibility for a Medicare prescription drug subsidy. Interim final rule with request for comments.
    Social Security Administration
    Fed Regist; 2010 Dec; 75(249):81843-6. PubMed ID: 21261125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Part D subsidies. Final rules.
    Social Security Administration (SSA)
    Fed Regist; 2005 Dec; 70(250):77663-85. PubMed ID: 16392171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More choice in health insurance marketplaces may reduce the value of the subsidies available to low-income enrollees.
    Taylor EA; Saltzman E; Bauhoff S; Pacula RL; Eibner C
    Health Aff (Millwood); 2015 Jan; 34(1):104-10. PubMed ID: 25561650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coverage for hepatitis C drugs in Medicare Part D.
    Jung JK; Feldman R; Cheong C; Du P; Leslie D
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP220-6. PubMed ID: 27266952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.
    Frankenfield DL; Howell BL; Wei II; Anderson KK
    Am J Health Syst Pharm; 2011 Jul; 68(14):1339-48. PubMed ID: 21719594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2008.
    Depue R; Stubbings J
    J Manag Care Pharm; 2008; 14(1):50-60. PubMed ID: 18240882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.
    Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM
    J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug coverage among elderly and disabled Americans: can Medicare-Part D reduce inequities in access?
    Kanavos P; Gemmill-Toyama M
    Int J Health Care Finance Econ; 2010 Sep; 10(3):203-18. PubMed ID: 20213234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who will be denied Medicare prescription drug subsidies because of the asset test?
    Rice T; Desmond K
    Am J Manag Care; 2006 Jan; 12(1):46-54. PubMed ID: 16402888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?
    Davidoff AJ; Stuart B; Shaffer T; Shoemaker JS; Kim M; Zacker C
    Health Aff (Millwood); 2010 Jun; 29(6):1255-63. PubMed ID: 20466775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.